Position in ANNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,082,490
+$197,919 QoQ
Shares Held
189,578
+18.7% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 216 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ANNX ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ANNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,082,490 | 189,578 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $884,571 | 159,670 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $634,844 | 126,463 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $404,439 | 132,603 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $330,086 | 137,536 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $263,252 | 136,400 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $727,700 | 141,852 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $805,108 | 135,998 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $620,629 | 126,659 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $587,782 | 81,978 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $269,312 | 59,320 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $140,915 | 59,710 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $193,705 | 55,030 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $106,243 | 38,917 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $434,034 | 37,775 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $712,409 | 38,281 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $828,503 | 36,806 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $707,024 | 25,396 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $394,798 | 15,773 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $396,496 | 13,116 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||